News Release
GXO Reports Third Quarter 2024 Results
- Third quarter revenue increased 28% year over year to a record
$3 .2 billion, with organic revenue growth of 3% - Signed approximately
$750 million in annualized revenue year to date; on track to win a record level of new business in 2024 - Sales pipeline increased 30% year over year to
$2.4 billion and stands at a two-year high - Reaffirmed full-year 2024 guidance
“We signed
“We’re seeing increasing demand for ecommerce capacity. This is a long-term structural tailwind that has been a key growth driver for us over the past five years. More than half of our new wins in the third quarter originated from e-fulfillment, and we also opened the largest ecommerce warehouse in
“Our performance gives us confidence in the acceleration of our organic growth in 2025 and beyond. GXO is well positioned to capitalize on the secular supply chain trends of complexity, ecommerce, automation and outsourcing, and to deliver long-term profitable growth.”
Third Quarter 2024 Results
Revenue increased to
Net income was
Adjusted earnings before interest, taxes, depreciation and amortization (“adjusted EBITDA1”) was $223 million, compared with
____________________________
1 For definitions of non-GAAP measures see the “Non-GAAP Financial Measures” section in this press release.
GXO generated
Cash Balances and Outstanding Debt
As of
Guidance
The company reaffirms its guidance for the full year 20242 as follows:
- Organic revenue growth1 of 2% to 5%;
- Adjusted EBITDA1 of
$805 million to$835 million ; - Adjusted diluted EPS1 of
$2.73 to$2.93 ; and - Adjusted EBITDA1 to free cash flow1 conversion of 30% to 40%.
Conference Call
GXO will hold a conference call on
About
Non-GAAP Financial Measures
As required by the rules of the
GXO’s non-GAAP financial measures in this press release include: adjusted earnings before interest, taxes, depreciation and amortization (“adjusted EBITDA”), adjusted EBITDA margin, adjusted earnings before interest, taxes and amortization (“adjusted EBITA”), adjusted EBITA, net of income taxes paid, adjusted EBITA margin, adjusted net income attributable to GXO, adjusted earnings per share (basic and diluted) (“adjusted EPS”), free cash flow, free cash flow conversion, organic revenue, organic revenue growth, net leverage ratio, net debt, and operating return on invested capital (“ROIC”).
____________________________
2 Our guidance reflects current FX rates.
We believe that the above adjusted financial measures facilitate analysis of our ongoing business operations because they exclude items that may not be reflective of, or are unrelated to, GXO’s core operating performance, and may assist investors with comparisons to prior periods and assessing trends in our underlying businesses. Other companies may calculate these non-GAAP financial measures differently, and therefore our measures may not be comparable to similarly titled measures used by other companies. GXO’s non-GAAP financial measures should only be used as supplemental measures of our operating performance.
Adjusted EBITDA, adjusted EBITA, adjusted net income attributable to GXO and adjusted EPS include adjustments for transaction and integration costs, litigation expenses as well as restructuring costs and other adjustments as set forth in the financial table below. Transaction and integration adjustments are generally incremental costs that result from an actual or planned acquisition, divestiture or spin-off and may include transaction costs, consulting fees, retention awards, internal salaries and wages (to the extent the individuals are assigned full-time to integration and transformation activities), and certain costs related to integrating and separating IT systems. Litigation expenses primarily relate to the settlement of ongoing legal matters. Restructuring costs primarily relate to severance costs associated with business optimization initiatives.
We believe that adjusted EBITDA, adjusted EBITDA margin, adjusted EBITA, adjusted EBITA, net of income taxes paid, and adjusted EBITA margin, improve comparability from period to period by removing the impact of our capital structure (interest and financing expenses), asset base (depreciation and amortization of intangible assets acquired), tax impacts and other adjustments as set out in the attached tables, which management has determined are not reflective of core operating activities and thereby assist investors with assessing trends in our underlying businesses.
We believe that organic revenue and organic revenue growth are important measures because they exclude the impact of foreign currency exchange rate fluctuations, revenue from acquired businesses and revenue from disposed business.
We believe that adjusted net income attributable to GXO and adjusted EPS improve the comparability of our operating results from period to period by removing the impact of certain costs and gains, which management has determined are not reflective of our core operating activities, including amortization of acquisition-related intangible assets.
We believe that free cash flow and free cash flow conversion are important measures of our ability to repay maturing debt or fund other uses of capital that we believe will enhance stockholder value. We calculate free cash flow as cash flow from operations less capital expenditures plus proceeds from sale of property and equipment. We calculate free cash flow conversion as free cash flow divided by adjusted EBITDA, expressed as a percentage.
We believe that net debt and net leverage ratio are important measures of our overall liquidity position and are calculated by adding bank overdrafts and removing cash and cash equivalents from our total debt and net debt as a ratio of our adjusted EBITDA. We calculate ROIC as our trailing twelve months adjusted EBITA, net of income taxes paid, divided by the average invested capital. We believe ROIC provides investors with an important perspective on how effectively GXO deploys capital and use this metric internally as a high-level target to assess overall performance throughout the business cycle.
Management uses these non-GAAP financial measures in making financial, operating and planning decisions and evaluating GXO’s ongoing performance.
With respect to our financial targets for full-year 2024 organic revenue growth, adjusted EBITDA, adjusted diluted EPS, and free cash flow conversion, a reconciliation of these non-GAAP measures to the corresponding GAAP measures is not available without unreasonable effort due to the variability and complexity of the reconciling items described above that we exclude from these non-GAAP target measures. The variability of these items may have a significant impact on our future GAAP financial results and, as a result, we are unable to prepare the forward-looking statements of income and cash flows prepared in accordance with GAAP, that would be required to produce such a reconciliation.
Forward-Looking Statements
This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements, including the acceleration of our organic revenue growth in 2025 and beyond and our full-year 2024 guidance. In some cases, forward-looking statements can be identified by the use of forward-looking terms such as “anticipate,” “estimate,” “believe,” “continue,” “could,” “intend,” “may,” “plan,” “potential,” “predict,” “should,” “will,” “expect,” “objective,” “projection,” “forecast,” “goal,” “guidance,” “outlook,” “effort,” “target,” “trajectory” or the negative of these terms or other comparable terms. However, the absence of these words does not mean that the statements are not forward-looking. These forward-looking statements are based on certain assumptions and analyses made by the company in light of its experience and its perception of historical trends, current conditions and expected future developments, as well as other factors the company believes are appropriate in the circumstances.
These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. Factors that might cause or contribute to a material difference include, but are not limited to, the risks discussed in our filings with the
All forward-looking statements set forth in this release are qualified by these cautionary statements and there can be no assurance that the actual results or developments anticipated by us will be realized or, even if substantially realized, that they will have the expected consequences to or effects on us or our business or operations. Forward-looking statements set forth in this release speak only as of the date hereof, and we do not undertake any obligation to update forward-looking statements to reflect subsequent events or circumstances, changes in expectations or the occurrence of unanticipated events, except to the extent required by law.
Investor Contact |
+1 (203) 769-7228 |
chris.jordan@gxo.com |
Media Contact |
+1 (203) 307-2809 |
matt.schmidt@gxo.com |
Condensed Consolidated Statements of Operations | ||||||||||||||||
(Unaudited) | ||||||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||||||
(Dollars in millions, shares in thousands, except per share amounts) | 2024 |
2023 |
2024 |
2023 |
||||||||||||
Revenue | $ | 3,157 | $ | 2,471 | $ | 8,459 | $ | 7,188 | ||||||||
Direct operating expense | 2,671 | 2,012 | 7,116 | 5,875 | ||||||||||||
Selling, general and administrative expense | 265 | 258 | 784 | 761 | ||||||||||||
Depreciation and amortization expense | 111 | 101 | 302 | 268 | ||||||||||||
Transaction and integration costs | 21 | 3 | 55 | 22 | ||||||||||||
Restructuring costs and other | 9 | 7 | 26 | 31 | ||||||||||||
Litigation expense (1) | (1 | ) | — | 59 | — | |||||||||||
Operating income | 81 | 90 | 117 | 231 | ||||||||||||
Other income (expense), net | (6 | ) | 7 | 1 | 8 | |||||||||||
Interest expense, net | (33 | ) | (14 | ) | (69 | ) | (41 | ) | ||||||||
Income before income taxes | 42 | 83 | 49 | 198 | ||||||||||||
Income tax expense | (7 | ) | (15 | ) | (11 | ) | (38 | ) | ||||||||
Net income | 35 | 68 | 38 | 160 | ||||||||||||
Net income attributable to Noncontrolling Interests (“NCI”) | (2 | ) | (2 | ) | (4 | ) | (4 | ) | ||||||||
Net income attributable to GXO | $ | 33 | $ | 66 | $ | 34 | $ | 156 | ||||||||
Earnings per share | ||||||||||||||||
Basic | $ | 0.28 | $ | 0.55 | $ | 0.28 | $ | 1.31 | ||||||||
Diluted | $ | 0.28 | $ | 0.55 | $ | 0.28 | $ | 1.31 | ||||||||
Weighted-average common shares outstanding | ||||||||||||||||
Basic | 119,461 | 118,941 | 119,387 | 118,883 | ||||||||||||
Diluted | 119,793 | 119,645 | 119,718 | 119,430 | ||||||||||||
(1) | On |
Condensed Consolidated Balance Sheets | ||||||||
(Unaudited) | ||||||||
(Dollars in millions, shares in thousands, except per share amounts) | 2024 | 2023 | ||||||
ASSETS | ||||||||
Current assets | ||||||||
Cash and cash equivalents | $ | 548 | $ | 468 | ||||
Accounts receivable, net of allowance of |
1,968 | 1,753 | ||||||
Other current assets | 443 | 347 | ||||||
Total current assets | 2,959 | 2,568 | ||||||
Long-term assets | ||||||||
Property and equipment, net of accumulated depreciation of |
1,161 | 953 | ||||||
Operating lease assets | 2,501 | 2,201 | ||||||
3,676 | 2,891 | |||||||
Intangible assets, net of accumulated amortization of |
1,061 | 567 | ||||||
Other long-term assets | 542 | 327 | ||||||
Total long-term assets | 8,941 | 6,939 | ||||||
Total assets | $ | 11,900 | $ | 9,507 | ||||
LIABILITIES AND EQUITY | ||||||||
Current liabilities | ||||||||
Accounts payable | $ | 748 | $ | 709 | ||||
Accrued expenses | 1,411 | 966 | ||||||
Current debt | 223 | 27 | ||||||
Current operating lease liabilities | 681 | 597 | ||||||
Other current liabilities | 369 | 327 | ||||||
Total current liabilities | 3,432 | 2,626 | ||||||
Long-term liabilities | ||||||||
Long-term debt | 2,556 | 1,620 | ||||||
Long-term operating lease liabilities | 2,067 | 1,842 | ||||||
Other long-term liabilities | 704 | 473 | ||||||
Total long-term liabilities | 5,327 | 3,935 | ||||||
Commitments and Contingencies | ||||||||
Stockholders’ Equity | ||||||||
Common Stock, |
1 | 1 | ||||||
Preferred Stock, |
— | — | ||||||
2,620 | 2,598 | |||||||
Retained earnings | 586 | 552 | ||||||
Accumulated Other Comprehensive Income (Loss) (“AOCIL”) | (101 | ) | (239 | ) | ||||
Total stockholders’ equity before NCI | 3,106 | 2,912 | ||||||
NCI | 35 | 34 | ||||||
Total equity | 3,141 | 2,946 | ||||||
Total liabilities and equity | $ | 11,900 | $ | 9,507 | ||||
Condensed Consolidated Statements of Cash Flows | ||||||||
(Unaudited) | ||||||||
Nine Months Ended |
||||||||
(In millions) | 2024 | 2023 | ||||||
Cash flows from operating activities: | ||||||||
Net income | $ | 38 | $ | 160 | ||||
Adjustments to reconcile net income to net cash provided by operating activities | ||||||||
Depreciation and amortization expense | 302 | 268 | ||||||
Stock-based compensation expense | 30 | 25 | ||||||
Deferred tax benefit | (37 | ) | (29 | ) | ||||
Other | 11 | 16 | ||||||
Changes in operating assets and liabilities | ||||||||
Accounts receivable | 50 | (23 | ) | |||||
Other assets | (21 | ) | (39 | ) | ||||
Accounts payable | (29 | ) | (69 | ) | ||||
Accrued expenses and other liabilities | 19 | 34 | ||||||
Net cash provided by operating activities | 363 | 343 | ||||||
Cash flows from investing activities: | ||||||||
Capital expenditures | (255 | ) | (205 | ) | ||||
Proceeds from sale of property and equipment | 16 | 13 | ||||||
Acquisition of businesses, net of cash acquired | (863 | ) | — | |||||
Cross-currency swap agreements settlement | (5 | ) | — | |||||
Net cash used in investing activities | (1,107 | ) | (192 | ) | ||||
Cash flows from financing activities: | ||||||||
Proceeds from debt, net | 1,085 | — | ||||||
Repayments of debt, net | (216 | ) | (139 | ) | ||||
Repayments of finance lease obligations | (32 | ) | (24 | ) | ||||
Taxes paid related to net share settlement of equity awards | (8 | ) | (7 | ) | ||||
Net cash provided by (used in) financing activities | 829 | (170 | ) | |||||
Effect of exchange rates on cash and cash equivalents | 14 | (2 | ) | |||||
Net increase (decrease) in cash, restricted cash and cash equivalents | 99 | (21 | ) | |||||
Cash, restricted cash and cash equivalents, beginning of period | 470 | 495 | ||||||
Cash, restricted cash and cash equivalents, end of period | $ | 569 | $ | 474 | ||||
Reconciliation of cash, restricted cash and cash equivalents | ||||||||
Cash and cash equivalents | $ | 548 | $ | 473 | ||||
Restricted Cash (included in Other long-term assets) | 21 | 1 | ||||||
Total cash, restricted cash and cash equivalents | $ | 569 | $ | 474 |
Key Data | ||||||||||||
Disaggregation of Revenue | ||||||||||||
(Unaudited) | ||||||||||||
Revenue disaggregated by geographical area was as follows: | ||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||
(In millions) | 2024 | 2023 | 2024 | 2023 | ||||||||
$ | 1,525 | $ | 958 | $ | 3,727 | $ | 2,695 | |||||
771 | 711 | 2,249 | 2,117 | |||||||||
242 | 216 | 680 | 610 | |||||||||
195 | 207 | 596 | 626 | |||||||||
147 | 133 | 421 | 396 | |||||||||
98 | 97 | 288 | 279 | |||||||||
Other | 179 | 149 | 498 | 465 | ||||||||
Total | $ | 3,157 | $ | 2,471 | $ | 8,459 | $ | 7,188 | ||||
The Company’s revenue can also be disaggregated by the customer’s primary industry. Revenue disaggregated by industries was as follows: | ||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||
(In millions) | 2024 | 2023 | 2024 | 2023 | ||||||||
Omnichannel retail | $ | 1,479 | $ | 1,051 | $ | 3,817 | $ | 3,041 | ||||
Technology and consumer electronics | 392 | 360 | 1,137 | 1,081 | ||||||||
Food and beverage | 344 | 362 | 986 | 1,004 | ||||||||
Industrial and manufacturing | 376 | 263 | 973 | 803 | ||||||||
Consumer packaged goods | 311 | 231 | 896 | 689 | ||||||||
Other | 255 | 204 | 650 | 570 | ||||||||
Total | $ | 3,157 | $ | 2,471 | $ | 8,459 | $ | 7,188 | ||||
Reconciliation of Net Income to Adjusted EBITDA | |||||||||||||||||||||||
and Adjusted EBITDA Margins | |||||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||||
Three Months Ended |
Nine Months Ended |
Year Ended |
Trailing Twelve Months Ended |
||||||||||||||||||||
(In millions) | 2024 |
2023 |
2024 |
2023 |
|||||||||||||||||||
Net income attributable to GXO | $ | 33 | $ | 66 | $ | 34 | $ | 156 | $ | 229 | $ | 107 | |||||||||||
Net income attributable to NCI | 2 | 2 | 4 | 4 | 4 | 4 | |||||||||||||||||
Net income | $ | 35 | $ | 68 | $ | 38 | $ | 160 | $ | 233 | $ | 111 | |||||||||||
Interest expense, net | 33 | 14 | 69 | 41 | 53 | 81 | |||||||||||||||||
Income tax expense | 7 | 15 | 11 | 38 | 33 | 6 | |||||||||||||||||
Depreciation and amortization expense | 111 | 101 | 302 | 268 | 361 | 395 | |||||||||||||||||
Transaction and integration costs | 21 | 3 | 55 | 22 | 34 | 67 | |||||||||||||||||
Restructuring costs and other | 9 | 7 | 26 | 31 | 32 | 27 | |||||||||||||||||
Litigation expense | (1 | ) | — | 59 | — | — | 59 | ||||||||||||||||
Unrealized (gain) loss on foreign currency contracts and other | 8 | (8 | ) | 4 | (12 | ) | (5 | ) | 11 | ||||||||||||||
Adjusted EBITDA (1) | $ | 223 | $ | 200 | $ | 564 | $ | 548 | $ | 741 | $ | 757 | |||||||||||
Revenue | $ | 3,157 | $ | 2,471 | $ | 8,459 | $ | 7,188 | |||||||||||||||
Operating income | $ | 81 | $ | 90 | $ | 117 | $ | 231 | |||||||||||||||
Operating income margin (2) | 2.6 | % | 3.6 | % | 1.4 | % | 3.2 | % | |||||||||||||||
Adjusted EBITDA margin (1)(3) | 7.1 | % | 8.1 | % | 6.7 | % | 7.6 | % | |||||||||||||||
(1) See the “Non-GAAP Financial Measures” section of this press release.
(2) Operating income margin is calculated as operating income divided by revenue for the period.
(3) Adjusted EBITDA margin is calculated as adjusted EBITDA divided by revenue for the period.
Reconciliation of Net Income to Adjusted EBITA | |||||||||||||||||||||||
and Adjusted EBITA Margins | |||||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||||
Three Months Ended |
Nine Months Ended |
Year Ended |
Trailing Twelve Months Ended |
||||||||||||||||||||
(In millions) | 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||
Net income attributable to GXO | $ | 33 | $ | 66 | $ | 34 | $ | 156 | $ | 229 | $ | 107 | |||||||||||
Net income attributable to NCI | 2 | 2 | 4 | 4 | 4 | 4 | |||||||||||||||||
Net income | $ | 35 | $ | 68 | $ | 38 | $ | 160 | $ | 233 | $ | 111 | |||||||||||
Interest expense, net | 33 | 14 | 69 | 41 | 53 | 81 | |||||||||||||||||
Income tax expense | 7 | 15 | 11 | 38 | 33 | 6 | |||||||||||||||||
Amortization of intangible assets acquired | 36 | 18 | 77 | 54 | 71 | 94 | |||||||||||||||||
Transaction and integration costs | 21 | 3 | 55 | 22 | 34 | 67 | |||||||||||||||||
Restructuring costs and other | 9 | 7 | 26 | 31 | 32 | 27 | |||||||||||||||||
Litigation expense | (1 | ) | — | 59 | — | — | 59 | ||||||||||||||||
Unrealized (gain) loss on foreign currency contracts and other | 8 | (8 | ) | 4 | (12 | ) | (5 | ) | 11 | ||||||||||||||
Adjusted EBITA (1) | $ | 148 | $ | 117 | $ | 339 | $ | 334 | $ | 451 | $ | 456 | |||||||||||
Revenue | $ | 3,157 | $ | 2,471 | $ | 8,459 | $ | 7,188 | |||||||||||||||
Adjusted EBITA margin (1)(2) | 4.7 | % | 4.7 | % | 4.0 | % | 4.6 | % | |||||||||||||||
(1) See the “Non-GAAP Financial Measures” section of this press release.
(2) Adjusted EBITA margin is calculated as adjusted EBITA divided by revenue for the period.
Reconciliation of Net Income to Adjusted Net Income | ||||||||||||||||
and Adjusted Earnings Per Share | ||||||||||||||||
(Unaudited) | ||||||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||||||
(Dollars in millions, shares in thousands, except per share amounts) | 2024 | 2023 | 2024 | 2023 | ||||||||||||
Net income | $ | 35 | $ | 68 | $ | 38 | $ | 160 | ||||||||
Net income attributable to NCI | (2 | ) | (2 | ) | (4 | ) | (4 | ) | ||||||||
Net income attributable to GXO | $ | 33 | $ | 66 | $ | 34 | $ | 156 | ||||||||
Amortization of intangible assets acquired | 36 | 18 | 77 | 54 | ||||||||||||
Transaction and integration costs | 21 | 3 | 55 | 22 | ||||||||||||
Restructuring costs and other | 9 | 7 | 26 | 31 | ||||||||||||
Litigation expense | (1 | ) | — | 59 | — | |||||||||||
Unrealized (gain) loss on foreign currency contracts and other | 8 | (8 | ) | 4 | (12 | ) | ||||||||||
Income tax associated with the adjustments above (1) | (11 | ) | (4 | ) | (40 | ) | (21 | ) | ||||||||
Discrete tax benefit (2) | — | — | — | (5 | ) | |||||||||||
Adjusted net income attributable to GXO (3) | $ | 95 | $ | 82 | $ | 215 | $ | 225 | ||||||||
Adjusted basic EPS (3) | $ | 0.80 | $ | 0.69 | $ | 1.80 | $ | 1.89 | ||||||||
Adjusted diluted EPS (3) | $ | 0.79 | $ | 0.69 | $ | 1.80 | $ | 1.88 | ||||||||
Weighted-average common shares outstanding | ||||||||||||||||
Basic | 119,461 | 118,941 | 119,387 | 118,883 | ||||||||||||
Diluted | 119,793 | 119,645 | 119,718 | 119,430 | ||||||||||||
(1) The income tax rate applied to items is based on the GAAP annual effective tax rate.
(2) Discrete tax benefit from intangible assets and the release of valuation allowances.
(3) See the “Non-GAAP Financial Measures” section of this press release.
Other Reconciliations | ||||||||||||||||
(Unaudited) | ||||||||||||||||
Reconciliation of Cash Flow from Operations to Free Cash Flow: | ||||||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||||||
(In millions) | 2024 | 2023 | 2024 | 2023 | ||||||||||||
Cash flow from operations (1) | $ | 198 | $ | 243 | $ | 363 | $ | 343 | ||||||||
Capital expenditures | (94 | ) | (55 | ) | (255 | ) | (205 | ) | ||||||||
Proceeds from sale of property and equipment | 6 | 3 | 16 | 13 | ||||||||||||
Free cash flow (2) | $ | 110 | $ | 191 | $ | 124 | $ | 151 | ||||||||
(1) Net cash provided by operating activities.
(2) See the “Non-GAAP Financial Measures” section of this press release.
Reconciliation of Revenue to Organic Revenue: | ||||||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||||||
(In millions) | 2024 | 2023 | 2024 | 2023 | ||||||||||||
Revenue | $ | 3,157 | $ | 2,471 | $ | 8,459 | $ | 7,188 | ||||||||
Revenue from acquired business (1) | (591 | ) | — | (1,050 | ) | — | ||||||||||
Revenue from disposed business (1) | — | (3 | ) | (1 | ) | (10 | ) | |||||||||
Foreign exchange rates | (35 | ) | — | (85 | ) | — | ||||||||||
Organic revenue (2) | $ | 2,531 | $ | 2,468 | $ | 7,323 | $ | 7,178 | ||||||||
Revenue growth (3) | 27.8 | % | 17.7 | % | ||||||||||||
Organic revenue growth (2)(4) | 2.6 | % | 2.0 | % | ||||||||||||
(1) The Company excludes revenue from acquired and disposed businesses for periods that are not comparable.
(2) See the “Non-GAAP Financial Measures” section of this press release.
(3) Revenue growth is calculated as the change in the period-over-period revenue divided by the prior period, expressed as a percentage.
(4) Organic revenue growth is calculated as the change in the period-over-period organic revenue divided by the prior period, expressed as a percentage.
Liquidity Reconciliations | ||||
(Unaudited) | ||||
Reconciliation of Total Debt and Net Debt: | ||||
(In millions) | ||||
Current debt | $ | 223 | ||
Long-term debt | 2,556 | |||
Total debt (1) | $ | 2,779 | ||
Less: Cash and cash equivalents (excluding restricted cash) | (548 | ) | ||
Net debt (2) | $ | 2,231 | ||
(1) Includes finance leases and other debt of
(2) See the “Non-GAAP Financial Measures” section of this press release.
Reconciliation of Total debt to Net income Ratio: |
|||
(In millions) | |||
Total debt | $ | 2,779 | |
Trailing twelve months net income | $ | 111 | |
Debt to net income ratio | 25.0x |
Reconciliation of Net Leverage Ratio: | |||
(In millions) | |||
Net debt | $ | 2,231 | |
Trailing twelve months adjusted EBITDA (1) | $ | 757 | |
Net leverage ratio (1) | 2.9x |
(1) See the “Non-GAAP Financial Measures” section of this press release.
Return on |
||||||||||||||||
(Unaudited) | ||||||||||||||||
Adjusted EBITA, net of income taxes paid: | ||||||||||||||||
Nine Months Ended |
Year Ended |
Trailing Twelve Months Ended |
||||||||||||||
(In millions) | 2024 | 2023 | ||||||||||||||
Adjusted EBITA (1) | $ | 339 | $ | 334 | $ | 451 | $ | 456 | ||||||||
Less: Cash paid for income taxes | (26 | ) | (57 | ) | (84 | ) | (53 | ) | ||||||||
Adjusted EBITA, net of income taxes paid (1) | $ | 313 | $ | 277 | $ | 367 | $ | 403 | ||||||||
(1) See the “Non-GAAP Financial Measures” section of this press release.
Return on |
||||||||||||
(In millions) | 2024 | 2023 | Average | |||||||||
Selected Assets: | ||||||||||||
Accounts receivable, net | $ | 1,968 | $ | 1,661 | $ | 1,815 | ||||||
Other current assets | 443 | 332 | 388 | |||||||||
Property and equipment, net | 1,161 | 923 | 1,042 | |||||||||
Selected Liabilities: | ||||||||||||
Accounts payable | (748 | ) | (597 | ) | (673 | ) | ||||||
Accrued expenses | (1,411 | ) | (975 | ) | (1,193 | ) | ||||||
Other current liabilities | (369 | ) | (275 | ) | (322 | ) | ||||||
Invested capital | $ | 1,044 | $ | 1,069 | $ | 1,057 | ||||||
Trailing twelve months net income to average invested capital | 10.5 | % | ||||||||||
Operating return on invested capital (1)(2) | 38.1 | % | ||||||||||
(1) | See the “Non-GAAP Financial Measures” section of this press release. |
(2) | The ratio of operating return on invested capital is calculated as trailing twelve months adjusted EBITA, net of income taxes paid, divided by the average invested capital. |
Source: GXO Logistics